A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.

NCT05421078 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia
Hypercholesterolemia
High Cholesterol

Interventions

DRUG: Obicetrapib
DRUG: Placebo

Sponsor

NewAmsterdam Pharma